CHRISTINE CURL: Open Payments
NPI 1215124219 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 77 payments from 14 companies in 2025. Trend: 2023 $1,579 · 2024 $1,986 · 2025 $1,361
Food & beverage: $1,361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $301 |
| UCB, Inc. | 12 | $154 |
| Janssen Biotech, Inc. | 8 | $151 |
| Amgen Inc. | 6 | $126 |
| E.R. Squibb & Sons, L.L.C. | 6 | $111 |
| Lilly USA, LLC | 5 | $97 |
| GENZYME CORPORATION | 3 | $89 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $83 |
| PFIZER INC. | 4 | $64 |
| Organon LLC | 1 | $59 |
Products named: SKYRIZI, Bimzelx, TREMFYA, OTEZLA, Sotyktu, DUPIXENT, BLU-U, TALTZ.
Industry payments across KS — which companies pay providers there.
